By 2026, medical science has entered a new era in which genes, data and technology are reshaping treatment. Breakthroughs in cancer therapies, mRNA vaccines, AI-driven diagnostics, liquid biopsies and affordable drugs are expanding globally, with the US, Europe, China and India playing key roles in making healthcare more precise and accessible.